TPTX - Turning Point Therapeutics EPS misses by $0.20 August, 06 2019 04:14 PM Turning Point Therapeutics Inc. Turning Point Therapeutics (NASDAQ:TPTX): Q2 GAAP EPS of -$0.70 misses by $0.20.More news on: Turning Point Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...